Skip to content

Kodiak Sciences Inc KOD Book value per share

Book value per share at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$291.77+10.4%
HRO
HarrowHROW
$0.77-51.1%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$2.60+65.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%
Vera Therapeutics logo
Vera TherapeuticsVERA
$6.99-16.8%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Calculated from Kodiak Sciences Inc’s reported figures.

Based on the most recent quarter.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's book value per share?
Kodiak Sciences Inc (KOD) reported book value per share of $1.81 in Q1 2026.
How has Kodiak Sciences Inc's book value per share changed year-over-year?
Kodiak Sciences Inc's book value per share decreased by 12.2% year-over-year, from $2.06 to $1.81.
What is the long-term trend for Kodiak Sciences Inc's book value per share?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's book value per share has grown at a -30.9% compound annual growth rate (CAGR), from $18.82 to $2.96.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.